Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis of randomized trials - Lincoff, AM; Wolski, K; Nicholls, SJ; Nissen, SE (JAMA, 2007)
doi:10.1001/jama.298.10.1180